Scarica l'app Stockscreener
15.88
0.19%
0.03
Dopo l'orario di chiusura:
15.88
Precedente Chiudi:
$15.85
Aprire:
$15.81
Volume 24 ore:
1.14M
Relative Volume:
0.44
Capitalizzazione di mercato:
$1.70B
Reddito:
$64.52M
Utile/perdita netta:
$-95.55M
Rapporto P/E:
-15.62
EPS:
-1.0169
Flusso di cassa netto:
$-84.65M
1 W Prestazione:
+0.00%
1M Prestazione:
-3.52%
6M Prestazione:
+160.33%
1 anno Prestazione:
+64.05%
Intervallo 1D:
$15.77
$15.98
Intervallo di 1 settimana:
$15.62
$16.11
Portata 52W:
$4.955
$18.89
Personalis Inc Stock (PSNL) Company Profile
Nome
Personalis Inc
Settore
Industria
Telefono
650-752-1300
Indirizzo
6600 DUMBARTON CIRCLE, FREMONT, CA
Compare PSNL vs TMO, DHR, NTRA, A, IQV
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PSNL
Personalis Inc
|
15.88 | 1.70B | 64.52M | -95.55M | -84.65M | -1.0169 |
TMO
Thermo Fisher Scientific Inc
|
684.89 | 253.24B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
232.97 | 163.77B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
404.90 | 58.36B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
175.96 | 49.61B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
273.60 | 45.03B | 16.63B | 1.39B | 2.12B | 8.0674 |
Personalis Inc Stock (PSNL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-10-06 | Downgrade | BTIG Research | Buy → Neutral |
| 2026-08-24 | Downgrade | Craig Hallum | Buy → Hold |
| 2025-12-02 | Ripresa | Morgan Stanley | Equal-Weight |
| 2025-05-15 | Iniziato | Guggenheim | Buy |
| 2025-03-17 | Iniziato | Craig Hallum | Buy |
| 2023-02-06 | Aggiornamento | Needham | Hold → Buy |
| 2022-01-07 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2021-11-05 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-03 | Downgrade | Needham | Buy → Hold |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-09-20 | Reiterato | Needham | Buy |
| 2021-05-06 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-01-28 | Iniziato | Truist | Buy |
| 2021-01-04 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-11-12 | Reiterato | Needham | Buy |
| 2020-11-06 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-10-19 | Iniziato | Citigroup | Buy |
| 2020-10-08 | Iniziato | BTIG Research | Buy |
| 2020-08-27 | Iniziato | H.C. Wainwright | Buy |
| 2020-08-18 | Iniziato | Needham | Buy |
| 2019-09-26 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Iniziato | BofA/Merrill | Neutral |
| 2019-07-15 | Iniziato | Cowen | Outperform |
| 2019-07-15 | Iniziato | Morgan Stanley | Overweight |
| 2019-07-15 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Personalis Inc Borsa (PSNL) Ultime notizie
PSNL Stock Notification: Personalis, Inc. is being Investigated after the $16.25 per share Merger Deal Announced – Investors are Alerted to Contact BFA Law - Business Wire
PSNL Stock Notification: Personalis, Inc. is being Investigated after the $16.25 per share Merger Deal Announced – Investors are Alerted to Contact BFA Law - FinancialContent
No merger-related layoffs are anticipated by Personalis (PSNL) as Tempus takeover awaits closing. - Stock Titan
Personalis (Nasdaq:PSNL)Stock Analysis - Simply Wall Street
BTIG downgrades Personalis stock rating to neutral on acquisition outlook - Investing.com
PSNL SC 13E3/A & SEC FilingsYahoo Finance - Yahoo! Finance Canada
Personalis SVP, chief legal officer Stephen Moore sells $33,542 in shares - Investing.com
Personalis CFO and COO Aaron Tachibana sells $47,540 in stock - Investing.com
Personalis president & CMO Chen sells $64,847 of PSNL stock - Investing.com
Personalis CEO Christopher Hall sells $120,984 in company stock - Investing.com
Personalis SVP, chief legal officer Stephen Moore sells $33,542 in shares - Investing.com Australia
Personalis SVP, chief legal officer Stephen Moore sells $33,542 in shares - Investing.com Canada
Personalis CEO Christopher Hall sells $120,984 in company stock By Investing.com - Investing.com Nigeria
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Centerspace (NYSE – CSR), Fulcrum Therapeutics, Inc. (Nasdaq – FULC), Weave Communications, Inc. (NYSE – WEAV), Personalis, Inc. (Nasdaq – PSNL) - GlobeNewswire Inc.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Centerspace (NYSE – CSR), Fulcrum Therapeutics, Inc. (Nasdaq – FULC), Weave Communications, Inc. (NYSE – WEAV), Personalis, Inc. (Nasdaq – PSNL) - Supply Chain Digital Magazine
Personalis President and CMO Richard Chen Executes Stock Sale for Tax Withholding - Kalkine Media
Personalis CLO Stephen Michael Moore Sells 2,068 Shares for RSU Tax Withholding - Kalkine Media
Tempus move on Personalis (NASDAQ: PSNL) hinges on cancer tests and data from 50 million patients - Stock Titan
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Weekly Recap: Intismeran win and Personalis 13% stake backs Tempus AI - tradingview.com
Personalized Cancer Vaccine Breakthrough Ignites Sequencing Sector, Tempus AI's Personalis Bid Faces Rivalry Speculation - finance.biggo.com
The Cancer Vaccine Gold Rush Has Begun. So Has the Race for Picks and Shovels. - WSJ
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Tempus AI shares rise 5.1% to $70 on Moderna cancer trial validation - scanx.trade
Personalis Stock Is Up 250% in the Past Year. It Needs to Turn a Profit Next. - webull.com
Personalis Inc Stock Historical Valuations | FRA:04X - GuruFocus
Personalis Inc Stock Operating Data - GuruFocus
PSNL SC 13E3 & SEC FilingsYahoo Finance - Yahoo! Finance Canada
Tempus AI (TEM) Jumped on Moderna’s Melanoma Win. Did its $1.5B Personalis Acquisition Just Get Validated? - Yahoo Finance
Personalis Stock Is Up 250% in the Past Year. It Needs to Turn a Profit Next. - Barchart.com
Why Personalis (PSNL) Is Up 24.0% After New VA MVP Genomics Task Order Win - webull.com
Why Personalis (PSNL) Is Up 24.0% After New VA MVP Genomics Task Order Win - simplywall.st
Personalis falls amid a downgrade as a competitive bid appears unlikely - Seeking Alpha
Tempus AI soars 40% in a week, adding $3.7 billion—over double the Personalis acquisition amount - TechStock²
Tempus AI (TEM) Is Up 39.5% After mRNA Melanoma Trial Win And Personalis DealWhat's Changed - Yahoo Finance
A Look at Personalis Inc (PSNL) After 8.8% Gain -- GF Value $2.4 - GuruFocus
Tempus AI Shares Jump $3 Billion After Moderna Victory Boosts Value of $1.5 Billion Personalis Stake - TechStock²
AMERIPRISE FINANCIAL INC Trims Personalis Inc (PSNL) Stake -- Shares Trade 590% Above GF Value - GuruFocus
Why Tempus AI (TEM) Is Up 22.8% After Buying the Platform Behind a Key mRNA Cancer Win - simplywall.st
Deep Track Capital, LP Trims Personalis Inc (PSNL) Stake -- Shar - GuruFocus
Personalis secures new Million Veteran Program task order - TipRanks
Personalis Receives New Task Order Under U.S. Veterans Affairs Contract For VA MVP - TradingView
Personalis wins up to $18.3M VA MVP task order, cumulative VA awards reach $243.3M - TradingView
Personalis (NASDAQ: PSNL) wins Million Veteran Program task order—how big is it? - Stock Titan
Tempus soars on coattails of Moderna/Merck cancer vaccine - Crain's Chicago Business
TEM Stock On Track For Best Week In 4 Months Following Personalis Deal Spotlight - TradingView
Personalis stock reaches 52-week high at 16.42 USD - Investing.com
Personalis stock reaches 52-week high at 16.42 USD By Investing.com - Investing.com Canada
Tempus AI Just Had Their Entire Strategy Validated By Moderna’s Vaccine Advance (TEM) - Seeking Alpha
TEM Stock On Track For Best Week In 4 Months Following Personalis Deal Spotlight - Stocktwits
Personalis Inc Azioni (PSNL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Personalis Inc Azioni (PSNL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Hall Christopher M | Chief Executive Officer |
Sep 18 '26 |
Sale |
16.22 |
7,459 |
120,985 |
228,527 |
| Chen Richard | President and CMO |
Sep 18 '26 |
Sale |
16.22 |
3,998 |
64,848 |
169,882 |
| Tachibana Aaron | CFO AND COO |
Sep 18 '26 |
Sale |
16.22 |
2,931 |
47,541 |
195,902 |
| Chen Richard | President and CMO |
Jul 15 '26 |
Option Exercise |
2.44 |
100,000 |
244,000 |
273,880 |
| Chen Richard | President and CMO |
Jul 15 '26 |
Sale |
15.15 |
100,000 |
1,515,000 |
173,880 |
| RICHARD CHEN | Officer |
Jul 15 '26 |
Proposed Sale |
15.03 |
100,000 |
1,503,000 |
0 |
| Hall Christopher M | Chief Executive Officer |
Jul 09 '26 |
Option Exercise |
1.61 |
100,000 |
161,000 |
335,986 |
| Hall Christopher M | Chief Executive Officer |
Jul 09 '26 |
Sale |
15.08 |
100,000 |
1,508,000 |
235,986 |
| Chris Hall | Director |
Jul 09 '26 |
Proposed Sale |
14.11 |
100,000 |
1,411,000 |
0 |
| Tachibana Aaron | CFO AND COO |
Jun 29 '26 |
Option Exercise |
5.32 |
4,982 |
26,504 |
203,815 |
9.10%
0.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):